GENEVA, July 31 -- LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. filed a patent application (CN2026/074831) for “NITROGEN-CONTAINING HETEROCYCLIC COMPOUND SMALL-MOLECULE INHIBITOR AND USE THEREOF”. With publication no. WO/2026/158633, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....